Clinical Trial Update: Protocol Calcineurin Inhibitor (CNI) Weaning [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a calcineurin inhibitor weaning protocol in kidney transplant recipients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Nantes University Hospital | Conditions: Function of Renal Transplant | Phase 3 | Status: TERMINATED